134 related articles for article (PubMed ID: 29421659)
1. RIP2 enhances cell survival by activation of NF-ĸB in triple negative breast cancer cells.
Jaafar R; Mnich K; Dolan S; Hillis J; Almanza A; Logue SE; Samali A; Gorman AM
Biochem Biophys Res Commun; 2018 Feb; 497(1):115-121. PubMed ID: 29421659
[TBL] [Abstract][Full Text] [Related]
2. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
Yuan Z; Jiang H; Zhu X; Liu X; Li J
Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of receptor-interacting protein 2 as a TNFR-associated factor 3 binding partner.
Cai X; Du J; Liu Y; Xia W; Liu J; Zou M; Wang Y; Wang M; Su H; Xu D
Gene; 2013 Apr; 517(2):205-11. PubMed ID: 23333941
[TBL] [Abstract][Full Text] [Related]
5. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
Li L; Bin LH; Li F; Liu Y; Chen D; Zhai Z; Shu HB
J Cell Sci; 2005 Feb; 118(Pt 3):555-63. PubMed ID: 15657077
[TBL] [Abstract][Full Text] [Related]
6. Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-κB signaling in triple-negative breast cancer cells.
Raman V; Fuentes Lorenzo JL; Stashenko EE; Levy M; Levy MM; Camarillo IG
Int J Oncol; 2017 Dec; 51(6):1801-1808. PubMed ID: 29075784
[TBL] [Abstract][Full Text] [Related]
7. PAX5 interacts with RIP2 to promote NF-κB activation and drug-resistance in B-lymphoproliferative disorders.
Wang D; Chen J; Li R; Wu G; Sun Z; Wang Z; Zhai Z; Fang F; Guo Y; Zhong Y; Jiang M; Xu H; Chen M; Shen G; Sun J; Yan B; Yu C; Tian Z; Xiao W
J Cell Sci; 2016 Jun; 129(11):2261-72. PubMed ID: 27122187
[TBL] [Abstract][Full Text] [Related]
8. Human procaspase-1 variants with decreased enzymatic activity are associated with febrile episodes and may contribute to inflammation via RIP2 and NF-κB signaling.
Heymann MC; Winkler S; Luksch H; Flecks S; Franke M; Ruß S; Ozen S; Yilmaz E; Klein C; Kallinich T; Lindemann D; Brenner S; Ganser G; Roesler J; Rösen-Wolff A; Hofmann SR
J Immunol; 2014 May; 192(9):4379-85. PubMed ID: 24706726
[TBL] [Abstract][Full Text] [Related]
9. Elevated IL-1β expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone.
Jeon M; Han J; Nam SJ; Lee JE; Kim S
Chem Biol Interact; 2016 Oct; 258():126-33. PubMed ID: 27567548
[TBL] [Abstract][Full Text] [Related]
10. Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer.
Song L; Chen X; Mi L; Liu C; Zhu S; Yang T; Luo X; Zhang Q; Lu H; Liang X
Cancer Sci; 2020 Nov; 111(11):4242-4256. PubMed ID: 32926492
[TBL] [Abstract][Full Text] [Related]
11. Budlein A methylacrylate demonstrates potent activity against triple-negative breast cancer by targeting IκBα kinase and exportin-1.
Wang XZ; Feng Y; Han YF; Bian Y; Liang J; Wen HM; Wu H
Toxicol Appl Pharmacol; 2020 Dec; 408():115263. PubMed ID: 33022283
[TBL] [Abstract][Full Text] [Related]
12. Enhanced autophagy reveals vulnerability of P-gp mediated epirubicin resistance in triple negative breast cancer cells.
Zhang LH; Yang AJ; Wang M; Liu W; Wang CY; Xie XF; Chen X; Dong JF; Li M
Apoptosis; 2016 Apr; 21(4):473-88. PubMed ID: 26767845
[TBL] [Abstract][Full Text] [Related]
13. Macrophages confer resistance to BET inhibition in triple-negative breast cancer by upregulating IKBKE.
Qiao J; Chen Y; Mi Y; Jin H; Wang L; Huang T; Li H; Song Y; Cao J; Wu B; Wang Q; Zou Z
Biochem Pharmacol; 2020 Oct; 180():114126. PubMed ID: 32603665
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
[TBL] [Abstract][Full Text] [Related]
15. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses.
Chin AI; Dempsey PW; Bruhn K; Miller JF; Xu Y; Cheng G
Nature; 2002 Mar; 416(6877):190-4. PubMed ID: 11894097
[TBL] [Abstract][Full Text] [Related]
16. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
Blanchard Z; Paul BT; Craft B; ElShamy WM
Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
[TBL] [Abstract][Full Text] [Related]
17. RIP2-beta: a novel alternative mRNA splice variant of the receptor interacting protein kinase RIP2.
Krieg A; Le Negrate G; Reed JC
Mol Immunol; 2009 Mar; 46(6):1163-70. PubMed ID: 19121870
[TBL] [Abstract][Full Text] [Related]
18. Dimethyl Fumarate Induces Apoptosis via Inhibition of NF-κB and Enhances the Effect of Paclitaxel and Adriamycin in Human TNBC Cells.
Tsurushima K; Tsubaki M; Takeda T; Matsuda T; Kimura A; Takefuji H; Okada A; Sakamoto C; Ishizaka T; Nishida S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955813
[TBL] [Abstract][Full Text] [Related]
19. RIP2 filament formation is required for NOD2 dependent NF-κB signalling.
Pellegrini E; Desfosses A; Wallmann A; Schulze WM; Rehbein K; Mas P; Signor L; Gaudon S; Zenkeviciute G; Hons M; Malet H; Gutsche I; Sachse C; Schoehn G; Oschkinat H; Cusack S
Nat Commun; 2018 Oct; 9(1):4043. PubMed ID: 30279485
[TBL] [Abstract][Full Text] [Related]
20. STC-1 expression is upregulated through an Akt/NF-κB-dependent pathway in triple-negative breast cancer cells.
Jeon M; Han J; Nam SJ; Lee JE; Kim S
Oncol Rep; 2016 Sep; 36(3):1717-22. PubMed ID: 27461417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
